Evaluation of Interleukin-6 Level Before Chemotherapy in Acute Lymphoblastic Leukemia L1 Standard-Risk and High-risk Patients
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 10 (B) , 2586-2590
Abstract
BACKGROUND: Acute lymphoblastic leukemia (ALL) is a malignancy originating from the clonal expansion of lymphoid progenitors that have undergone neoplastic transformation at various stages of differentiation. Interleukin-6 (IL-6) is a pleiotropic inflammatory cytokine produced by various cell types, including T-cells, macrophages, and stromal cells in response to tumor necrosis factor-alpha and interleukin-1. AIM: This study aims to evaluate serum levels of IL-6 before chemotherapy in standard-risk (SR) and high-risk (HR) ALL patients. METHODS: The research method was a cross-sectional study conducted on ALL patients who were treated at Dr. Wahidin Sudirohusodo hospital from April 2021 to June 2021. A total of 60 ALL patients were included in the study. Serum IL-6 specimens were examined before the patient received chemotherapy. RESULTS: The results showed that from 60 samples of ALL patients, 30 were SR and 30 were HR. Elevated levels of IL-6 before chemotherapy were found in both SR and HR ALL but were significantly higher in the HR group compared to the SR group with p value = 0.022. The cutoff point of 64.23 ng/mL for HRALL patients was obtained through ROC with a sensitivity of 63.3%, specificity of 63.3%, a positive predictive value of 63.3%, and a negative predictive value of 63.3%. Adjusted odds ratio are 2,983 with 95% confidence interval of 1.044–8.527. CONCLUSION: IL-6 levels among HR ALL were higher than SR. Elevated levels of IL-6 were found in both SR and HR ALL.Keywords
This publication has 13 references indexed in Scilit:
- Effect of allogeneic blood transfusion on levels of IL‑6 and sIL‑R2 in peripheral blood of children with acute lymphocytic leukemiaOncology Letters, 2018
- Epidemiological patterns of leukaemia in 184 countries: a population-based studyThe Lancet Haematology, 2018
- Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemiaHematology-American Society Hematology Education Program, 2016
- Trends in childhood leukemia incidence over two decades from 1992 to 2013International Journal of Cancer, 2016
- Damage-associated molecular patterns in cancer: a double-edged swordOncogene, 2016
- Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infectionOncology Reports, 2016
- Role of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase to Predict Risk of Death in Children with Acute Myeloid LeukemiaBioMed Research International, 2015
- Childhood B-acute lymphoblastic leukemia: a genetic updateExperimental Hematology & Oncology, 2014
- Impact of Interleukin-6 in Hematological MalignanciesTransfusion Medicine and Hemotherapy, 2013
- Gender Differences in Cancer Susceptibility: An Inadequately Addressed IssueFrontiers in Genetics, 2012